A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 388, Issue 2, 2014, Pages 257-269

  Carotenuto, Marianeve ^a,b   De Antonellis, Pasqualino ^a,b   Chiarolla, Cristina Maria ^a,b   Attanasio, Carmela ^a,b   Damiani, Valentina ^a,b   Boffa, Iolanda ^a,b   Aiese, Nadia ^a,b   Pedone, Emilia ^c   Accordi, Benedetta ^d   Basso, Giuseppe ^d   Navas, Luigi ^b   Imbimbo, Ciro ^b   Zollo, Massimo ^a,b,e  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Competitive permeable peptide (CPP); H Prune; Nm23 H1; Prostate cancer

Indexed keywords

CARRIER PROTEIN; CELL PENETRATING PEPTIDE; NUCLEOSIDE DIPHOSPHATE KINASE NM23;

ADENOVIRIDAE; ANIMAL; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; DRUG SCREENING; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL-PENETRATING PEPTIDES; HUMANS; MALE; MICE; MICE, NUDE; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROSTATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84939896153     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-014-1035-8     Document Type: Article

References (48)

1. Andolfo I, De Martino D, Liguori L, Petrosino G, Troncone G, Tata N, Galasso A, Roma C, Chiancone F, Zarrilli S, Arrigoni G, Staibano S, Imbimbo C, Zollo M (2011) Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue. Naunyn Schmiedeberg's Arch Pharmacol 384:489-498
2. Bemis LT, Schedin P (2000) Reproductive state of rat mammary glandstroma modulates human breast cancer cell migration and invasion.Cancer Res 60:3414-3418
3. Bierhoff H, Dundr M, Michels AA, Grummt I (2008) Phosphorylation by casein kinase 2 facilitates rRNA gene transcription by promoting dissociation of TIF-IA fromelongating RNA polymerase I.Mol Cell Biol 28:4988-4998
4. Biggs J, Hersperger E, Steeg PS, Liotta LA, Shearn A (1990) A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase. Cell 63: 933-940
5. Biondi RM, Engel M, Sauane M, Welter C, Issinger OG, Jimenez de Asua L, Passeron S (1996) Inhibition of nucleoside diphosphatekinase activity by in vitro phosphorylation by protein kinase CK2.Differential phosphorylation of NDP kinases in HeLa cells in culture.FEBS Lett 399:183-187
6. Carotenuto M, Pedone E, Diana D, de Antonellis P, Dzeroski S, Marino N, Navas L, Di Dato V, Scoppettuolo MN, Cimmino F, Correale S, Pirone L, Monti SM, Bruder E, Zenko B, Slavkov I, Pastorino F, Ponzoni M, Schulte JH, Schramm A, Eggert A, Westermann F, Arrigoni G, Accordi B, Basso G, Saviano M, Fattorusso R, Zollo M (2013) Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction. Sci Rep 3:1351
7. Choo AY, Blenis J (2006) TORgeting oncogene addiction for cancertherapy. Cancer Cell 9:77-79
8. Cuello F, Schulze RA, Heemeyer F, Meyer HE, Lutz S, Jakobs KH, Niroomand F, Wieland T (2003) Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gbeta subunits. Complex formation of NDPK B with Gbeta gamma dimers and phosphorylation of His-266 IN Gbeta. J Biol Chem 278:7220-7226
9. D'Angelo A, Garzia L, Andre A, Carotenuto P, Aglio V, Guardiola O, Arrigoni G, Cossu A, Palmieri G, Aravind L, Zollo M (2004) Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer Cell 5:137-149
10. Davies MA, Kim SJ, Parikh NU, Dong Z, Bucana CD, Gallick GE (2002) Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin Cancer Res:Off J Am Assoc Cancer Res 8:1904-1914
11. de Antonellis P, Liguori L, Falanga A, Carotenuto M, Ferrucci V, Andolfo I, Marinaro F, Scognamiglio I, Virgilio A, De Rosa G, Galeone A, Galdiero S, Zollo M (2013) MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines. Naunyn Schmiedeberg's Arch Pharmacol 386:287-302
12. Fiano V, Ghimenti C, Imarisio S, Silengo L, Schiffer D (2004) PAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation. Anticancer Res 24:2643-2647
13. Galasso A, Zollo M (2009) The Nm23-H1-h-Prune complex in cellular physiology: a 'tip of the iceberg' protein network perspective. Mol Cell Biochem 329:149-159
14. Garzia L, D'Angelo A, Amoresano A, Knauer SK, Cirulli C, Campanella C, Stauber RH, Steegborn C, Iolascon A, Zollo M (2008) Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility. Oncogene 27: 1853-1864
15. Hockla A, Miller E, Salameh MA, Copland JA, Radisky DC, Radisky ES (2012) PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer. Mol Cancer Res: MCR 10:1555-1566
16. Igawa M, Rukstalis DB, Tanabe T, Chodak GW (1994) High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res 54:1313-1318
17. Jessen BA, Lee L, Koudriakova T, Haines M, Lundgren K, Price S, Nonomiya J, Lewis C, Stevens GJ (2007) Peripheral white blood cell toxicity induced by broad spectrum cyclin-dependent kinase inhibitors. J Appl Toxicol: JAT 27:133-142
18. Korshunov AG, Sycheva RV, Golanov AV (1998) Immunohistochemical study of neoplasm-associated proteins in cerebellum medulloblastomas.Arkh Patol 60:8-14
19. Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR (1984) Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44:3522-3529
20. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO (2000) The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32:247-258
21. Lang CH, Frost RA (2005) Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle. J Cell Physiol 203:144-155
22. le Nguyen XT, Mitchell BS (2013) Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA. Proc Natl AcadSci U S A 110:20681-20686
23. Leone A, Flatow U, VanHoutte K, Steeg PS (1993) Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinomacell line: effects on tumor metastatic potential, colonization andenzymatic activity. Oncogene 8:2325-2333
24. Marino N, Marshall JC, Steeg PS (2011) Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1. Naunyn Schmiedeberg's Arch Pharmacol 384:351-362
25. Marino N, Marshall JC, Collins JW, Zhou M, Qian Y, Veenstra T, Steeg PS (2013) Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis. Cancer Res 73:5949-5962
26. Memmott RM, Dennis PA (2009) Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal 21:656-664
27. Molineux G (2003) Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients. Anticancer Drugs 14: 259-264
28. Niitsu N, Okabe-Kado J, Okamoto M, Takagi T, Yoshida T, Aoki S, Hirano M, Honma Y (2001) Serumnm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Blood 97:1202-1210
29. Noguchi T, Oue N, Wada S, Sentani K, Sakamoto N, Kikuchi A, Yasui W (2009) h-Prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma.Ann Surg Oncol 16:1390-1396
30. Oda Y, Naka T, Takeshita M, Iwamoto Y, Tsuneyoshi M (2000) Comparison of histological changes and changes in nm23 and c- MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Hum Pathol 31:709-716
31. Oliveira LA, Artigiani-Neto R, Waisberg DR, Fernandes LC, Lima Fde O, Waisberg J (2010) NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival. Arq Gastroenterol 47:361-367
32. Oue N, Yoshida K, Noguchi T, Sentani K, Kikuchi A, Yasui W (2007) Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer. Cancer Sci 98:1198-1205
33. Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS (2005) Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J Natl Cancer Inst 97:632-642
34. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ (1996) Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res: Off J Am Assoc Cancer Res 2:1627-1636
35. Reymond A, Volorio S, Merla G, Al-Maghtheh M, Zuffardi O, Bulfone A, Ballabio A, Zollo M (1999) Evidence for interaction between human PRUNE and nm23-H1 NDPKinase. Oncogene 18:7244-7252
36. Roymans D, Willems R, Vissenberg K, De Jonghe C, Grobben B, Claes P, Lascu I, Van Bockstaele D, Verbelen JP, Van Broeckhoven C, Slegers H (2000) Nucleoside diphosphate kinase beta (Nm23-R1/ NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma. Exp Cell Res 261:127-138
37. Saffran DC, Raitano AB, Hubert RS, Witte ON, Reiter RE, Jakobovits A (2001) Anti-PSCA mAbs inhibit tumor growth and metastasis formationand prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci U S A 98:2658-2663
38. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME (1988) Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.Cancer Res 48:6550-6554
39. Stravodimos K, Constantinides C, Manousakas T, Pavlaki C, Pantazopoulos D, Giannopoulos A, Dimopoulos C (2000) Immunohistochemical expression of transforming growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation with clinicopathological parameters. Anticancer Res 20:3823-3828
40. Sugatani T, Alvarez U, Hruska KA (2003) PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility. J Biol Chem 278:5001-5008
41. Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N (2004) nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation. Int J Cancer J Int Cancer 108:207-211
42. Tammenkoski M, Koivula K, Cusanelli E, Zollo M, Steegborn C, Baykov AA, Lahti R (2008) Humanmetastasis regulator protein H-prune is a short-chain exopolyphosphatase. Biochemistry 47:9707-9713
43. Tripkovic A, Tripkovic I, Tomic S, Kovacic A, Grandic L, Capkun V (2012) The role of nm23 gene in colorectal carcinogenesis. Acta Clin Croat 51:43-49
44. Wagner PD, Vu ND (2000) Histidine to aspartate phosphotransferase activity of nm23 proteins: phosphorylation of aldolase C on Asp-319. Biochem J 346(Pt 3):623-630
45. Wallet V, Mutzel R, Troll H, Barzu O, Wurster B, Veron M, Lacombe ML (1990) Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst 82: 1199-1202
46. Zamboni WC, D'Argenio DZ, Stewart CF, MacVittie T, Delauter BJ, Farese AM, Potter DM, Kubat NM, Tubergen D, Egorin MJ (2001) Pharmacodynamic model of topotecan-induced time course of neutropenia. Clin Cancer Res Off J AmAssoc Cancer Res 7:2301-2308
47. Zhang Q, McCorkle JR, Novak M, Yang M, Kaetzel DM (2011) Metastasis suppressor function of NM23-H1 requires its 3′-5′ exonuclease activity. Int J Cancer 128:40-50
48. Zollo M, Andre A, Cossu A, Sini MC, D'Angelo A, Marino N, Budroni M, Tanda F, Arrigoni G, Palmieri G (2005) Overexpression of hprune in breast cancer is correlated with advanced disease status. Clin Cancer Res: Off J Am Assoc Cancer Res 11:199-205